Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company ▾	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
PTN	Palatin Technologies Inc Manufacturing · Year ended 2025-06-30 · USD	$0	-$17.31M	n/a	n/a	-100.0%	-$32.15
OVID	Ovid Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.25M	-$17.41M	-240.1%	-13.3%	n/m	n/a
ORKA	Oruka Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.43M	n/a	-22.3%	n/a	n/a
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
OGN	Organon & Co. Manufacturing · Year ended 2025-12-31 · USD	$6.22B	$187.00M	3.0%	24.9%	-2.9%	$0.72
ORGO	Organogenesis Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$564.17M	$37.03M	6.6%	12.3%	17.0%	$0.15
IRD	Opus Genetics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.20M	-$49.59M	-349.3%	-323.1%	29.1%	-$0.80
OTLC	Oncotelic Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$249.28M	n/a	94.9%	n/a	$0.59
ONCO	Onconetix, Inc. Manufacturing · Year ended 2025-12-31 · USD	$815.4K	-$14.03M	n/m	-89.0%	-67.7%	-$16.56
OKUR	OnKure Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.52M	n/a	-105.9%	n/a	-$4.40
OLMA	Olema Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$162.45M	n/a	-33.9%	n/a	-$1.87
OSTX	OS Therapies Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.75M	n/a	n/a	n/a	-$0.98
ORMP	Oramed Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$64.05M	n/a	32.1%	n/a	$1.50
OGEN	Oragenics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.84M	n/a	-118.9%	n/a	-$4.56
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
ONCY	Oncolytics Biotech Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.76M	n/a	n/a	n/a	-$0.30
OMER	Omeros Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.35M	n/a	n/a	n/a	-$0.05
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
NVCT	Nuvectis Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.44M	n/a	-143.6%	n/a	-$1.32
NUVB	Nuvation Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.90M	-$204.63M	-325.3%	-66.9%	699.0%	-$0.60
NRIX	Nurix Therapeutics, Inc. Manufacturing · Year ended 2025-11-30 · USD	$83.98M	-$264.46M	-314.9%	-49.1%	54.0%	-$3.05
NKTX	Nkarta, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$104.08M	n/a	-33.3%	n/a	-$1.41
NXTC	NextCure, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.84M	n/a	-159.8%	n/a	-$19.65
NXTS	Nexentis Technologies Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$4.00M	n/a	-25.0%	n/a	-$8.61
NCEL	NewcelX Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.30M	n/a	-114.5%	n/a	$2.16

Rows per page: 2550 100